A BARF1-specific mAb as a new immunotherapeutic tool for the management of EBV-related tumors

The use of monoclonal antibodies (mAb) for the diagnosis and treatment of malignancies is acquiring an increasing clinical importance, thanks to their specificity, efficacy and relative easiness of use. However, in the context of Epstein-Barr virus (EBV)-related malignancies, only cancers of B-cell...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncoimmunology
Hlavní autoři: Turrini, Riccardo, Merlo, Anna, Martorelli, Debora, Faè, Damiana Antonia, Sommaggio, Roberta, Montagner, Isabella Monia, Barbieri, Vito, Marin, Oriano, Zanovello, Paola, Dolcetti, Riccardo, Rosato, Antonio
Médium: Artigo
Jazyk:Inglês
Vydáno: Taylor & Francis 2017
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5414862/
https://ncbi.nlm.nih.gov/pubmed/28507812
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2017.1304338
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky